Origin Life Sciences, Inc. (OLSI)

Origin Life Sciences will go public soon, but the exact IPO date is still unknown.

IPO Price

$4.00

Shares Offered

1,875,000

Deal Size

$7.50M

Origin Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-8.84	-8.84	-6.33
Depreciation & Amortization	0.09	0.09	0.09
Share-Based Compensation	0.08	0.08	3.1
Other Operating Activities	7.31	7.31	2.22
Operating Cash Flow	-1.36	-1.36	-0.92
Share Issuance / Repurchase	0.33	0.33	0.55
Debt Issued / Paid	1.58	1.58	0.18
Financing Cash Flow	1.91	1.91	0.73
Net Cash Flow	0.55	0.55	-0.19
Free Cash Flow	-1.36	-1.36	-0.92

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).